JU

Jasim Uddin

No bio yet

Links


Org chart


Teams


Offices

This person is not in any offices


Infinity Pharmaceuticals

Infinity Pharmaceuticals, Inc., is a clinical-stage biotechnology company developing eganelisib (IPI-549), a potentially first-in-class, oral, immuno-oncology macrophage reprogramming therapeutic which addresses a fundamental biologic mechanism of immune suppression in cancer in multiple clinical studies.